Celsius Therapeutics

Cambridge, United States

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

$83.0M raised

Mar 2022

Series B

Biotechnology Emergency Medicine Genetics Health Care Precision Medicine

Top Investors

Catalio Capital Management Casdin Capital S32 Google Ventures Third Rock Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Celsius Therapeutics

How much funding has Celsius Therapeutics raised?

Celsius Therapeutics has raised $83.0M in total funding. The most recent round was Series B. The last funding was announced in March 2022.

Who are Celsius Therapeutics's investors?

Celsius Therapeutics's investors include Catalio Capital Management, Casdin Capital, S32, Google Ventures, Third Rock Ventures.

Where is Celsius Therapeutics headquartered?

Celsius Therapeutics is headquartered in Cambridge, United States.

What does Celsius Therapeutics do?

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

What stage is Celsius Therapeutics at?

Celsius Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2022.

MLA

"Celsius Therapeutics — Funding & Investors." VCBacked, March 24, 2022, https://www.vcbacked.co/company/celsius-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Celsius Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/celsius-therapeutics

Wikipedia (cite web)

{{cite web |title=Celsius Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/celsius-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K